NASDAQ Biotechnology Index
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals.
Criteria
In order to remain included within the index, the components must meet the following criteria:
- The security U.S. listing must be exclusively on the NASDAQ National Market (unless the security was dually listed on another U.S. market prior to January 1, 2004 and has continuously maintained such listing).
- The issuer of the security must be classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals.
- The security may not be issued by an issuer currently in bankruptcy proceedings.
- The security must have a market capitalization of at least $200 million.
- The security must have an average daily trading volume of at least 100,000 shares.
- The issuer of the security may not have entered into a definitive agreement or other arrangement which would likely result in the security no longer being Index.
- The issuer of the security may not have annual financial statements with an audit opinion that is currently withdrawn.
- The issuer of the security must have "seasoned" on NASDAQ or another recognized market for at least 6 months; in the case of spin-offs, the operating history of the spin-off will be considered.
Components
This list of companies is current as of 24 January 2012. The list is reviewed twice annually in May and November, although components may be removed at any time.
- Achillion Pharmaceuticals Inc. NASDAQ: ACHN
- Acorda Therapeutics Inc. NASDAQ: ACOR
- Affymetrix Inc. NASDAQ: AFFX
- Affymax Inc. NASDAQ: AFFY
- Akorn Inc. NASDAQ: AKRX
- Alkermes plc NASDAQ: ALKS
- Alnylam Pharmaceuticals Inc. NASDAQ: ALNY
- AMAG Pharmaceuticals Inc. NASDAQ: AMAG
- Amgen Inc. NASDAQ: AMGN
- Amylin Pharmaceuticals Inc. NASDAQ: AMLN
- Amarin Corporation NASDAQ: AMRN
- ARIAD Pharmaceuticals Inc. NASDAQ: ARIA
- Arena Pharmaceuticals Inc. NASDAQ: ARNA
- ArQule Inc. NASDAQ: ARQL
- Array BioPharma Inc. NASDAQ: ARRY
- Astex Pharmaceuticals Inc. NASDAQ: ASTX
- Auxilium Pharmaceuticals Inc. NASDAQ: AUXL
- AVEO Pharmaceuticals Inc. NASDAQ: AVEO
- AVI BioPharma Inc. NASDAQ: AVII
- Avanir Pharmaceuticals Inc. NASDAQ: AVNR
- BioCryst Pharmaceuticals Inc. NASDAQ: BCRX
- BioMarin Pharmaceutical Inc. NASDAQ: BMRN
- BioSante Pharmaceuticals Inc. NASDAQ: BPAX
- Cadence Pharmaceuticals Inc. NASDAQ: CADX
- China Biologic Products Inc. NASDAQ: CBPO
- Columbia Laboratories Inc. NASDAQ: CBRX
- Cubist Pharmaceuticals Inc. NASDAQ: CBST
- Celgene Corporation NASDAQ: CELG
- Curis Inc. NASDAQ: CRIS
- Cardiome Pharma Corporation NASDAQ: CRME
- Cytori Therapeutics Inc. NASDAQ: CYTX
- Depomed Inc. NASDAQ: DEPO
- Dendreon Corporation NASDAQ: DNDN
- Durect Corporation NASDAQ: DRRX
- Dyax Corp. NASDAQ: DYAX
- Endocyte Inc. NASDAQ: ECYT
- Endo Pharmaceuticals Holdings I NASDAQ: ENDP
- Enzon Pharmaceuticals Inc. NASDAQ: ENZN
- Exelixis Inc. NASDAQ: EXEL
- Geron Corporation NASDAQ: GERN
- Genomic Health Inc. NASDAQ: GHDX
- Gilead Sciences Inc. NASDAQ: GILD
- Gen-Probe Inc. NASDAQ: GPRO
- Grifols, S.A. NASDAQ: GRFS
- GTx Incorporated NASDAQ: GTXI
- Halozyme Therapeutics Inc. NASDAQ: HALO
- Human Genome Sciences Inc. NASDAQ: HGSI
- Hi-Tech Pharmacal Co. Inc. NASDAQ: HITK
- Idenix Pharmaceuticals Inc. NASDAQ: IDIX
- Illumina Inc. NASDAQ: ILMN
- ImmunoGen Inc. NASDAQ: IMGN
- Immunomedics Inc. NASDAQ: IMMU
- Incyte Corporation NASDAQ: INCY
- Impax Laboratories Inc. NASDAQ: IPXL
- Ironwood Pharmaceuticals Inc. NASDAQ: IRWD
- Isis Pharmaceuticals Inc. NASDAQ: ISIS
- ISTA Pharmaceuticals Inc. NASDAQ: ISTA
- InterMune Inc. NASDAQ: ITMN
- Ligand Pharmaceuticals Incorpor NASDAQ: LGND
- Life Technologies Corporation NASDAQ: LIFE
- Luminex Corporation NASDAQ: LMNX
- Lexicon Pharmaceuticals Inc. NASDAQ: LXRX
- MAP Pharmaceuticals Inc. NASDAQ: MAPP
- Maxygen Inc. NASDAQ: MAXY
- The Medicines Company NASDAQ: MDCO
- Medivation Inc. NASDAQ: MDVN
- Micromet Inc. NASDAQ: MITI
- MannKind Corporation NASDAQ: MNKD
- Momenta Pharmaceuticals Inc. NASDAQ: MNTA
- Myriad Genetics Inc. NASDAQ: MYGN
- Mylan Inc. NASDAQ: MYL
- Neurocrine Biosciences Inc. NASDAQ: NBIX
- Nektar Therapeutics NASDAQ: NKTR
- NPS Pharmaceuticals Inc. NASDAQ: NPSP
- Novavax, Inc. NASDAQ: NVAX
- Obagi Medical Products Inc. NASDAQ: OMPI
- Oncothyreon Inc. NASDAQ: ONTY
- Onyx Pharmaceuticals Inc. NASDAQ: ONXX
- Optimer Pharmaceuticals Inc. NASDAQ: OPTR
- Osiris Therapeutics Inc. NASDAQ: OSIR
- Pacific Biosciences of California Inc. NASDAQ: PACB
- PDL BioPharma Inc. NASDAQ: PDLI
- Progenics Pharmaceuticals Inc. NASDAQ: PGNX
- Perrigo Company NASDAQ: PRGO
- Pain Therapeutics NASDAQ: PTIE
- Questcor Pharmaceuticals Inc. NASDAQ: QCOR
- Qiagen N.V. NASDAQ: QGEN
- QLT Inc. NASDAQ: QLTI
- Ardea Biosciences Inc. NASDAQ: RDEA
- Regeneron Pharmaceuticals Inc. NASDAQ: REGN
- Rigel Pharmaceuticals Inc. NASDAQ: RIGL
- SciClone Pharmaceuticals Inc. NASDAQ: SCLN
- Seattle Genetics Inc. NASDAQ: SGEN
- Sangamo BioSciences Inc. NASDAQ: SGMO
- Sagent Pharmaceuticals Inc. NASDAQ: SGNT
- Shire plc NASDAQ: SHPGY
- SIGA Technologies Inc. NASDAQ: SIGA
- Salix Pharmaceuticals Ltd. NASDAQ: SLXP
- Synta Pharmaceuticals Corp. NASDAQ: SNTA
- Santarus Inc. NASDAQ: SNTS
- Spectrum Pharmaceuticals Inc. NASDAQ: SPPI
- Sequenom Inc. NASDAQ: SQNM
- Sinovac Biotech Ltd. NASDAQ: SVA
- Savient Pharmaceuticals Inc. NASDAQ: SVNT
- Techne Corporation NASDAQ: TECH
- Theravance Inc. NASDAQ: THRX
- Targacept Inc. NASDAQ: TRGT
- United Therapeutics Corporation NASDAQ: UTHR
- Vical Incorporated NASDAQ: VICL
- Vanda Pharmaceuticals Inc. NASDAQ: VNDA
- ViroPharma Incorporated NASDAQ: VPHM
- Vertex Pharmaceuticals Incorporated NASDAQ: VRTX
- Vivus Inc. NASDAQ: VVUS
- Warner Chilcott NASDAQ: WCRX
- XenoPort Inc. NASDAQ: XNPT
Historical changes
November 2011 changes
In November 2011 the following were added:
- Amarin Corporation plc NASDAQ: AMRN
- BioSante Pharmaceuticals Inc NASDAQ: BPAX
- Endocyte Inc NASDAQ: ECYT
- Grifols S.A.NASDAQ: GRFS)
- Oncothyreon Inc NASDAQ: ONTY
- SciClone Pharmaceuticals Inc NASDAQ: SCLN
- Sagent Pharmaceuticals Inc NASDAQ: SGNT
The following were removed from the index:
- Alexza Pharmaceuticals Inc NASDAQ: ALXA
- Albany Molecular Research Inc NASDAQ: AMRI
- BioMimetic Therapeutics Inc NASDAQ: BMTI
- Cytokinetics Incorporated NASDAQ: CYTK
- Flamel Technologies S.A. NASDAQ: FLML
- Nabi Biopharmaceuticals NASDAQ: NABI
- Orexigen Therapeutics Inc NASDAQ: OREX
- POZEN Inc NASDAQ: POZN
- StemCells Inc NASDAQ: STEM
- Zalicus Inc NASDAQ: ZLCS
Investing
This index is tracked by an exchange-traded fund, iShares Nasdaq Biotechnology (NASDAQ: IBB).
External links
|